Akhmal Yusof – CEO, Clinical Research Malaysia (CRM)
Dr Akhmal Yusof, CEO of CRM sheds light on the capacity for all stages of clinical research in Malaysia. He discusses the importance of human resources for the country’s research…
Clinical Research Malaysia (CRM) is a non-profit organization wholly owned by the Government of Malaysia. It was established in June 2012 to promote Malaysia as a preferred global destination for industry sponsored clinical research (ISR). CRM provides a range of services to enable and facilitate sponsors (primarily from the pharmaceutical and medical device industries) and contract research organizations (CROs) to initiate a wide spectrum of clinical trials in Malaysia.
CRM’s key functions encompasses three core components, the first of which is securing clinical trials. This is done through advertising and promotional activities, participation in key conferences, involvement in clinical trial distribution and strategic collaborations with major stakeholders. The second component involves closing the deals through a comprehensive feasibility study, convincing site review operation and implementation of an efficient financial, administration and approval process. The third component is conducting the trials. This is achieved through our high quality Study Coordinators and Principal Investigators, effective standard operating procedures, quality assurance of study sites and support services.
CRM Contact Details
Clinical Research Malaysia
Suite E-10-20, Amcorp Business Suites, Menara Melawangi,
Amcorp Trade Centre, No.18, Jalan Persiaran Barat,
46050 Petaling Jaya, Selangor Darul Ehsan, Malaysia.
T: +603 7960 5153
F: +603 7932 1940
E: contact@clinicalresearch.my
W: www.clinicalresearch.my
Get connected socially,
facebook.com/clinicalresearchmalaysia
twitter.com/clinicalrsrchmy
youtube.com/ClinicalRsrchMy
linkedin.com/company/clinical-research-malaysia
Dr Akhmal Yusof, CEO of CRM sheds light on the capacity for all stages of clinical research in Malaysia. He discusses the importance of human resources for the country’s research…
Clinical Research Malaysia’s CEO discusses the need for Malaysia to focus on high quality pivotal trials rather than simply on a high number of trials. He shares with us the…
The Pharmaceutical Services Division has been around since 1951, what have been the major shifts in its objectives since then? When the pharmacy service came into existence in this country…
One of the key factors for the growth in the pharmaceutical market has been the increasing professionalism of healthcare in Malaysia. How does the MMA contribute to the professionalism of…
Before joining Nycomed you spent a year working at the Drug Control Authority (DCA). What did your regulatory friends say when you told them you were off to join the…
When we spoke to Herbert Dittmar of Bayer, he said that there were no specific challenges in Malaysia that could not be found elsewhere. How do you convince companies of…
Would you give our readers an insight into the government’s attempts to foster a better environment for FDI in Malaysia? Over the last year, the significant development has been the…
Can you give our readers an outline of Bayer’s background in Malaysia and its current organisational division? Herbert Dittmar (HD): Bayer has been in Malaysia for around fifty years. It…
Kebangsaan Malaysia (UKM). Singapore and Taiwan are known for their high level of basic research and their focus on Biotechnology. Philip Yeo, Chairman of Spring Singapore told us that Biomedical…
Nowadays we can talk of an abundance of information coming from companies like Frost& Sullivan, IMS and even consultancies who are producing their own data. As a leader in market…
You have worked in the pharmaceutical industry for many years starting with Novartis and you have spent the last eight years working for Lundbeck. What are the major changes that…
Pharmaceutical Executive is a magazine about executives, their experience and their perspectives on the pharmaceutical industry. You have worked in Australia, Hong Kong and now you are the general manager…
You spent most of your career in the pharmaceutical industry with Bristol Meyers Squibb and earlier on for NV Organon which you joined in 1998. In 2007 you left to…
You have spent much of your time working in the USA and came to Malaysia in 2008 as Country Manager. What were your expectations of Malaysia before you arrived and…
See our Cookie Privacy Policy Here